Natco Pharma

Market Cap

14,206.10 Cr

EPS

77.34

PE Ratio

7.66

Dividend Yield

1.19 %

Industry

Healthcare

52 Week High

1,639.00

52 Week low

790.60

PB Ratio

2.00

Debt to Equity

0.05

Sector

Pharmaceuticals

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Analyst Rating

- By Refinitiv from8 analysts

Analysts have suggested that investors can buy this stock

Buy50.00 %

50.00 %

Hold12.50 %

12.50 %

Sell37.50 %

37.50 %

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,643.75	4,00,521.00	33.42	49,887.20	12.06	9,648	13.77	33.47
Divis Laboratories	5,757.05	1,58,705.10	73.83	8,184.00	0.89	1,600	64.53	44.68
Cipla	1,475.75	1,19,502.60	23.86	26,520.70	14.17	4,155	47.38	53.61
Torrent Pharmaceuticals	3,039.35	1,04,781.00	55.18	10,785.70	11.59	1,656	13.54	40.36
Dr Reddys Laboratories	1,151.80	97,705.30	17.90	28,905.40	12.36	5,578	1.69	29.40
Mankind Pharma	2,327.75	96,889.30	47.03	10,615.60	19.57	1,942	-16.38	37.28
Zydus Life Science	885.35	90,525.80	19.64	19,831.50	13.82	3,831	29.92	36.58
Lupin	1,905.35	90,213.10	30.33	20,141.50	19.94	1,936	38.82	33.59
Aurobindo Pharma	1,115.15	65,122.40	18.38	29,559.20	17.55	3,169	-10.04	40.08
Abbott	28,941.95	62,536.00	46.09	6,097.20	10.80	1,201	16.01	54.66

Growth Rate

Revenue Growth

46.78 %

Net Income Growth

94.09 %

Cash Flow Change

42.69 %

ROE

61.58 %

ROCE

61.92 %

EBITDA Margin (Avg.)

23.08 %

Quarterly Financial Results

Quarterly Financials	Mar 2015	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Revenue	194	218	239	281	395	330	464	676	564	432	432	574	788	575	584	580	487	513	519	513	477	582	828	386	360	427	415	591	611	919	453	513	927	1,160	1,061	796	1,110	1,411	1,435	651
Expenses	151	166	185	227	302	248	356	410	324	291	305	276	385	321	323	348	307	301	351	354	327	392	526	273	255	301	307	459	615	489	337	387	559	613	573	491	571	558	567	436
EBITDA	42	51	54	54	93	82	108	266	241	140	127	298	403	254	261	232	179	212	168	160	151	190	302	113	105	127	109	132	-5	430	116	127	368	548	487	305	539	853	868	215
Operating Profit %	21 %	23 %	22 %	17 %	23 %	24 %	23 %	39 %	43 %	32 %	29 %	51 %	50 %	40 %	41 %	37 %	33 %	39 %	28 %	27 %	28 %	30 %	34 %	23 %	23 %	27 %	19 %	18 %	-3 %	45 %	22 %	22 %	38 %	46 %	44 %	35 %	47 %	59 %	59 %	8 %
Depreciation	13	13	13	13	12	13	14	14	14	15	16	17	18	18	20	21	22	22	22	25	31	28	29	30	30	34	35	36	38	40	42	42	41	44	44	44	56	44	46	47
Interest	9	8	8	4	4	3	4	5	6	4	4	4	3	3	5	6	5	7	6	5	4	4	3	3	4	2	4	5	7	4	4	4	3	4	4	5	6	5	4	4
Profit Before Tax	31	38	40	50	77	66	90	248	221	121	107	276	382	232	235	205	152	184	139	129	117	158	271	80	71	91	70	91	-50	386	70	81	324	500	440	256	478	804	818	164
Tax	-23	11	11	13	14	19	24	53	44	28	23	59	83	51	54	45	32	41	22	24	24	36	67	17	18	16	5	11	1	65	14	19	49	80	71	44	91	135	142	31
Net Profit	53	27	29	37	63	48	66	195	176	94	84	217	300	181	182	159	120	143	118	104	93	122	204	63	53	75	65	80	-51	320	57	62	276	420	369	213	386	669	677	132
EPS in ₹	16.41	1.70	9.05	2.13	3.86	2.74	3.79	11.18	10.10	5.59	4.82	12.29	16.26	9.84	9.89	8.65	6.59	7.87	6.55	5.75	5.17	6.74	11.12	3.44	2.91	4.11	3.57	4.41	-2.77	22.55	3.11	3.41	15.11	23.26	20.60	11.88	21.56	37.32	37.81	7.43

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	1,384	1,822	2,318	3,715	4,303	4,588	4,792	5,109	5,657	6,906
Fixed Assets	710	710	833	1,019	1,227	1,584	2,023	2,312	2,427	2,491
Current Assets	483	837	1,087	2,131	2,347	2,326	2,345	2,487	3,000	4,024
Capital Work in Progress	129	212	336	480	638	518	223	130	64	137
Investments	0	22	32	77	169	112	304	308	392	539
Other Assets	545	878	1,116	2,140	2,270	2,373	2,242	2,360	2,774	3,739
Total Liabilities	1,384	1,822	2,318	3,715	4,303	4,588	4,792	5,109	5,657	6,906
Current Liabilities	414	493	627	592	729	685	526	710	683	973
Non Current Liabilities	119	28	38	47	83	118	143	135	101	80
Total Equity	851	1,301	1,653	3,076	3,491	3,785	4,123	4,264	4,874	5,853
Reserve & Surplus	813	1,261	1,614	3,035	3,453	3,737	4,085	4,227	4,837	5,817
Share Capital	33	35	35	37	37	36	37	37	37	36

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	2	90	-1	-2	7	-9	6	85	21	-62
Investing Activities	-120	-176	-299	-1,116	-611	-175	-107	4	-465	-1,026
Operating Activities	93	112	346	464	669	417	299	47	849	1,212
Financing Activities	29	154	-48	651	-51	-251	-186	35	-363	-247

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Promoter	48.87 %	48.87 %	48.87 %	48.86 %	48.81 %	48.80 %	48.80 %	48.82 %	48.84 %	49.76 %	49.71 %	49.71 %	49.71 %	49.71 %	49.62 %	49.62 %
FIIs	0.01 %	0.03 %	0.03 %	0.03 %	0.03 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	16.14 %	17.45 %	17.51 %	17.94 %
DIIs	9.64 %	9.16 %	8.99 %	9.23 %	7.55 %	6.75 %	13.70 %	14.93 %	15.38 %	15.02 %	14.01 %	11.23 %	9.70 %	7.87 %	6.75 %	5.57 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	15.66 %	16.47 %	16.56 %	16.54 %	17.48 %	18.45 %	20.13 %	19.83 %	20.24 %	20.20 %	19.49 %	21.24 %	20.60 %	21.59 %	22.60 %	23.34 %
Others	25.83 %	25.47 %	25.56 %	25.34 %	26.14 %	26.00 %	17.37 %	16.42 %	15.54 %	15.02 %	16.79 %	17.82 %	3.85 %	3.39 %	3.52 %	3.53 %
No of Share Holders	85,509	87,667	88,439	88,421	85,828	92,449	1,21,336	1,35,397	1,53,663	1,55,181	1,63,753	2,07,571	2,28,467	2,51,485	3,02,944	3,45,332